BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22350005)

  • 1. Dedifferentiated peripheral chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of four cases.
    Franchi A; Baroni G; Sardi I; Giunti L; Capanna R; Campanacci D
    Virchows Arch; 2012 Mar; 460(3):335-42. PubMed ID: 22350005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathologic features of osteochondroma with malignant transformation].
    Zheng L; Zhang HZ; Huang J; Tang J; Liu L; Jiang ZM
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):609-13. PubMed ID: 20079189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes.
    Rozeman LB; de Bruijn IH; Bacchini P; Staals EL; Bertoni F; Bovée JV; Hogendoorn PC
    Mod Pathol; 2009 Nov; 22(11):1489-98. PubMed ID: 19734846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous multifocal bone sarcomas--a case report and molecular pathologic investigation.
    Walter H; Schneider-Stock R; Mellin W; Günther T; Nebelung W; Roessner A
    Gen Diagn Pathol; 1995 May; 141(1):67-74. PubMed ID: 8542510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis.
    Bovée JV; Cleton-Jansen AM; Rosenberg C; Taminiau AH; Cornelisse CJ; Hogendoorn PC
    J Pathol; 1999 Dec; 189(4):454-62. PubMed ID: 10629543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Next-Generation Sequencing Identifies Molecular and Genetic Events in Dedifferentiated Chondrosarcoma.
    Lucas CG; Grenert JP; Horvai A
    Arch Pathol Lab Med; 2021 Aug; 145(8):1009-1017. PubMed ID: 33147331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features.
    Makise N; Sekimizu M; Konishi E; Motoi T; Kubo T; Ikoma H; Watanabe SI; Okuma T; Hiraoka N; Fukayama M; Kawai A; Ichikawa H; Yoshida A
    Mod Pathol; 2019 Mar; 32(3):435-445. PubMed ID: 30291346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma.
    Bovée JV; van den Broek LJ; Cleton-Jansen AM; Hogendoorn PC
    Lab Invest; 2000 Dec; 80(12):1925-34. PubMed ID: 11140704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dedifferentiated chondrosarcomas arising in preexisting osteochondromas.
    Staals EL; Bacchini P; Mercuri M; Bertoni F
    J Bone Joint Surg Am; 2007 May; 89(5):987-93. PubMed ID: 17473135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT.
    de Andrea CE; Reijnders CM; Kroon HM; de Jong D; Hogendoorn PC; Szuhai K; Bovée JV
    Oncogene; 2012 Mar; 31(9):1095-104. PubMed ID: 21804604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periosteal chondrosarcoma: a histopathological and molecular analysis of a rare chondrosarcoma subtype.
    Cleven AH; Zwartkruis E; Hogendoorn PC; Kroon HM; Briaire-de Bruijn I; Bovée JV
    Histopathology; 2015 Oct; 67(4):483-90. PubMed ID: 25648524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dedifferentiated chondrosarcoma mimicking a giant cell tumor. Is this low grade dedifferentiated chondrosarcoma?
    Knösel T; Werner M; Jung A; Kirchner T; Dürr HR
    Pathol Res Pract; 2014 Mar; 210(3):194-7. PubMed ID: 24405942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of p53 with loss of heterozygosity in the osteosarcomatous component of a dedifferentiated chondrosarcoma.
    Grote HJ; Schneider-Stock R; Neumann W; Roessner A
    Virchows Arch; 2000 May; 436(5):494-7. PubMed ID: 10881744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma.
    Dobashi Y; Sugimura H; Sato A; Hirabayashi T; Kanda H; Kitagawa T; Kawaguchi N; Imamura T; Machinami R
    Diagn Mol Pathol; 1993 Dec; 2(4):257-63. PubMed ID: 8118603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dedifferentiated chondrosarcoma arising in an osteochondroma.
    Park YK; Yang MH; Ryu KN; Chung DW
    Skeletal Radiol; 1995 Nov; 24(8):617-9. PubMed ID: 8614864
    [No Abstract]   [Full Text] [Related]  

  • 16. A distinct phenotype characterizes tumors from a putative genetic trait involving chondrosarcoma and breast cancer occurring in the same patient.
    Cleton-Jansen AM; Timmerman MC; van de Vijver MJ; van Asperen CJ; Kroon HM; Eilers PH; Hogendoorn PC
    Lab Invest; 2004 Feb; 84(2):191-202. PubMed ID: 14661035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 expression in dedifferentiated chondrosarcoma.
    Simms WW; Ordóñez NG; Johnston D; Ayala AG; Czerniak B
    Cancer; 1995 Jul; 76(2):223-7. PubMed ID: 8625095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myxoid chondrosarcoma (chordoid sarcoma) of bone: a report of two cases and review of the literature.
    Kilpatrick SE; Inwards CY; Fletcher CD; Smith MA; Gitelis S
    Cancer; 1997 May; 79(10):1903-10. PubMed ID: 9149016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating Morphology and Genetics in the Diagnosis of Cartilage Tumors.
    de Andrea CE; San-Julian M; Bovée JVMG
    Surg Pathol Clin; 2017 Sep; 10(3):537-552. PubMed ID: 28797501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rb-loss is associated with high malignancy in chondrosarcoma.
    Röpke M; Boltze C; Meyer B; Neumann HW; Roessner A; Schneider-Stock R
    Oncol Rep; 2006 Jan; 15(1):89-95. PubMed ID: 16328039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.